Citadel Advisors’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-61,329
| Closed | -$10K | – | 4573 |
|
|
2017
Q3 | $10K | Buy |
+61,329
| New | +$10K | ﹤0.01% | 3589 |
|
|
2017
Q1 | – | Sell |
-63,789
| Closed | -$20K | – | 4489 |
|
|
2016
Q4 | $20K | Buy |
63,789
+53,621
| +527% | +$16.8K | ﹤0.01% | 3459 |
|
|
2016
Q3 | $6K | Sell |
10,168
-10,156
| -50% | -$5.99K | ﹤0.01% | 3510 |
|
|
2016
Q2 | $13K | Sell |
20,324
-4,946
| -20% | -$3.16K | ﹤0.01% | 3278 |
|
|
2016
Q1 | $17K | Buy |
25,270
+7,966
| +46% | +$5.36K | ﹤0.01% | 3194 |
|
|
2015
Q4 | $12K | Buy |
+17,304
| New | +$12K | ﹤0.01% | 3763 |
|
|
2015
Q1 | – | Sell |
-21,347
| Closed | -$7K | – | 4214 |
|
|
2014
Q4 | $7K | Sell |
21,347
-16,267
| -43% | -$5.33K | ﹤0.01% | 3770 |
|
|
2014
Q3 | $8K | Buy |
37,614
+11,136
| +42% | +$2.37K | ﹤0.01% | 3458 |
|
|
2014
Q2 | $8K | Sell |
26,478
-7,354
| -22% | -$2.22K | ﹤0.01% | 3372 |
|
|
2014
Q1 | $14K | Sell |
33,832
-19,079
| -36% | -$7.9K | ﹤0.01% | 3505 |
|
|
2013
Q4 | $13K | Sell |
52,911
-538
| -1% | -$132 | ﹤0.01% | 2978 |
|
|
2013
Q3 | $14K | Buy |
+53,449
| New | +$14K | ﹤0.01% | 2831 |
|